Latest News
All Times Eastern
- Pelorus Capital prices first-ever commercial real estate CLO in the cannabis space
- Visa stock price target raised to $255 from $240 at Mizuho
- Mastercard stock price target raised to $435 from $400 at Mizuho
- Airbnb stock price target raised to $145 from $125 at Mizuho
- Barron's Walmart Boosts Stake in Flipkart. Why U.S. Companies Love India.
- Penske Automotive downgraded to underweight from neutral at J.P. Morgan
- Xpeng upgraded to neutral from underweight at J.P. Morgan
- Trip.com upgraded to overweight from neutral at J.P. Morgan
- Sirius XM upgraded to neutral from sell at Seaport Research
- Barron's Apple Grapples With Weak Smartphone Market. This Analyst Says Buy the Stock Anyway.
to be replaced
Allarity Therapeutics Inc.
ALLRUS
$
0.70
26.62%
Premarket
$
3.3300
Before Hours Volume:
361.85K
| Close | Chg | Chg % |
|---|---|---|
| $2.6300 | -0.0600 | -2.23% |
Volume: 280.37K
65 Day Avg: 371.53K
2.5000
Day Range
2.8000
2.5000
52 Week Range
3,276.0000
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
ALLR Overview
Key Data
- Open $2.7000
- Day Range 2.5000 - 2.8000
- 52 Week Range 2.5000 - 3,276.0000
- Market Cap $2.26M
- Shares Outstanding 860.79K
- Public Float N/A
- Beta 1.17
- Rev. per Employee N/A
- P/E Ratio N/A
- EPS -$2,452.2740
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest 63K 07/14/23
- % of Float Shorted N/A
- Average Volume 371.53K
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 1
Full Ratings
Allarity Therapeutics Inc.
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company was founded on April 4, 2021 and is headquartered in Boston, MA.